Latest from Companies

Market close: Vaccine news energises Covid-sensitive stocks

The New Zealand sharemarket had a slight gain.

Vaccine battle throws up market disclosure issues

Vaccine science has the power to shake the market. So what rules should govern disclosure?

Vital Healthcare talks up unitholder returns

Vital executives upbeat at AGM after a strong result.

Fare dinkum: $25 Jetstar sale on thousands of seats

Airline says it has 10,000 fares at $25 from February next year

Fran O'Sullivan: SkyCity looks to luck of the Irish for rocky road ahead

Casino firm's new boss has to deal with uncertainty after executive departures.

Jarden Brief: Wall Street kicks off week on a high

Jarden's daily update on the biggest market moves and shakes.

The story behind the three high-profile SkyCity resignations

What really happened at SkyCity?

Market close: NZX continues rise, SkyCity falls on exec departures

The New Zealand sharemarket continued its merry way.

Market close: Mainfreight, Xero make strong gains

While the two growth stocks hogged the limelight, the S&P/NZX 50 Index had a flat day.

Synlait completes trifecta with capital raise

Synlait's successful capital raising comes as the company resolves a number of issues.

'A significant step': Major airline resumes flights in New Zealand

Quarantine requirements in NZ and Hong Kong put the brakes on leisure travel.

Air NZ's Dreamliner engine problems - the final ruling

In one case the broken blade showered the aircraft's fuselage with shredded metal.

Infratil earnings buoyed by Vodafone, CDC contributions

Acquisitions lead to jump in manager incentive fees.

Rebuilding Air NZ's exec: Back for the future with new CFO

New recruit has recently been involved in sale of NZ retirement village firm for $1.3b

Jarden Brief: Embattled Revlon shares surge 30 per cent

Jarden's daily update on the latest market moves and shakes.

'I've lost four weeks of my life': Fletcher boss on his month in quarantine

"I've lost four weeks of my life now in quarantine." - Ross Taylor.